Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Advances in developing HIV-1 viral load assays for resource-limited settings.

Wang S, Xu F, Demirci U.

Biotechnol Adv. 2010 Nov-Dec;28(6):770-81. doi: 10.1016/j.biotechadv.2010.06.004. Review.

2.

Low-cost assays for monitoring HIV infected individuals in resource-limited settings.

Balakrishnan P, Iqbal HS, Shanmugham S, Mohanakrishnan J, Solomon SS, Mayer KH, Solomon S.

Indian J Med Res. 2011 Dec;134(6):823-34. doi: 10.4103/0971-5916.92628. Review.

3.

Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings.

Steegen K, Luchters S, De Cabooter N, Reynaerts J, Mandaliya K, Plum J, Jaoko W, Verhofstede C, Temmerman M.

J Virol Methods. 2007 Dec;146(1-2):178-87.

PMID:
17686534
4.

The measurement of HIV-1 viral load in resource-limited settings: how and where?

Rouet F, Rouzioux C.

Clin Lab. 2007;53(3-4):135-48. Review.

PMID:
17447649
5.

Comparative evaluation of a reverse transcriptase based assay for HIV-1 viral load quantitation in resource limited settings.

Kokkayil P, Kurapati S, Negi N, Vajpayee M.

J Virol Methods. 2014 Jul;203:1-4. doi: 10.1016/j.jviromet.2014.02.021.

PMID:
24671025
6.

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.

Zhou Z, Wagar N, DeVos JR, Rottinghaus E, Diallo K, Nguyen DB, Bassey O, Ugbena R, Wadonda-Kabondo N, McConnell MS, Zulu I, Chilima B, Nkengasong J, Yang C.

PLoS One. 2011;6(11):e28184. doi: 10.1371/journal.pone.0028184.

7.

Emerging technologies for point-of-care management of HIV infection.

Shafiee H, Wang S, Inci F, Toy M, Henrich TJ, Kuritzkes DR, Demirci U.

Annu Rev Med. 2015;66:387-405. doi: 10.1146/annurev-med-092112-143017. Review.

PMID:
25423597
8.

Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting.

Gerlach J, Sequeira M, Alvarado V, Cerpas C, Balmaseda A, Gonzalez A, de Los Santos T, Levin CE, Amador JJ, Domingo GJ.

J Int AIDS Soc. 2010 Nov 5;13:43. doi: 10.1186/1758-2652-13-43.

9.

Clinical performance of an in-house real-time RT-PCR assay using a fluorogenic LUX primer for quantitation of human immunodeficiency virus type-1 (HIV-1).

Rekhviashvili N, Stevens W, Marinda E, Gonin R, Stevens G, McIntyre J, Wood R.

J Virol Methods. 2007 Dec;146(1-2):14-21.

PMID:
17628709
10.

Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay.

Sivapalasingam S, Wangechi B, Marshed F, Laverty M, Essajee S, Holzman RS, Valentine F.

PLoS One. 2009 Aug 28;4(8):e6828. doi: 10.1371/journal.pone.0006828.

11.

Monitoring of human immunodeficiency virus infection in resource-constrained countries.

Crowe S, Turnbull S, Oelrichs R, Dunne A.

Clin Infect Dis. 2003 Jul 1;37(Suppl 1):S25-35.

13.

Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries.

Balakrishnan P, Solomon S, Kumarasamy N, Mayer KH.

Indian J Med Res. 2005 Apr;121(4):345-55. Review.

PMID:
15817948
14.

Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring.

Greengrass VL, Turnbull SP, Hocking J, Dunne AL, Tachedjian G, Corrigan GE, Crowe SM.

Curr HIV Res. 2005 Apr;3(2):183-90.

PMID:
15853722
15.

Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay.

Elbeik T, Loftus RA, Beringer S.

Expert Rev Mol Diagn. 2002 May;2(3):275-85.

PMID:
12050866
16.

Low cost HIV-1 quantitative RT-PCR assay in resource-limited settings: improvement and implementation.

Fibriani A, Farah N, Kusumadewi I, Pas SD, van Crevel R, van der Ven A, Boucher CA, Schutten M.

J Virol Methods. 2012 Oct;185(1):118-23. doi: 10.1016/j.jviromet.2012.06.015.

PMID:
22766178
17.

Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study.

Mine M, Bedi K, Maruta T, Madziva D, Tau M, Zana T, Gaolathe T, Moyo S, Seipone K, Ndwapi N, Essex M, Marlink R.

J Virol Methods. 2009 Jul;159(1):93-7. doi: 10.1016/j.jviromet.2009.03.008.

PMID:
19442851
18.

Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.

Boyer S, March L, Kouanfack C, Laborde-Balen G, Marino P, Aghokeng AF, Mpoudi-Ngole E, Koulla-Shiro S, Delaporte E, Carrieri MP, Spire B, Laurent C, Moatti JP; Stratall ANRS 12110/ESTHER Study Group..

Lancet Infect Dis. 2013 Jul;13(7):577-86. doi: 10.1016/S1473-3099(13)70073-2.

PMID:
23602084
19.

Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.

BĂ©lec L, Bonn JP.

Future Microbiol. 2011 Nov;6(11):1251-60. doi: 10.2217/fmb.11.121. Review.

PMID:
22082287
20.

Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.

Bronze M, Aitken SC, Wallis CL, Steegen K, Stuyver LJ, de Wit TF, Stevens W.

J Virol Methods. 2013 Dec;194(1-2):300-7. doi: 10.1016/j.jviromet.2013.08.015.

PMID:
23994150
Items per page

Supplemental Content

Support Center